Literature DB >> 34295990

Histopathologic and electron microscopic investigation of the damage to liver tissue caused by parenteral nutrition combined with starvation in rabbits.

Semra Gürünlüoğlu1, Mehmet Gül2, Harika Gözükara Bağ3.   

Abstract

AIM OF THE STUDY: To conduct a histopathological examination of the damaging effects of the combination of parenteral nutrition (PN) with starvation on liver tissue using transmission electron and light microscopy.
MATERIAL AND METHODS: Four groups (n = 14 each) consisting of equal numbers of female and male New Zealand rabbits were formed: a group left completely unfed and receiving full-dose PN (full-dose PN group), a group provided with feed covering half its nutritional needs and receiving half-dose PN (half-dose PN + oral nutrition group), a group provided with feed covering half its nutritional needs (semi-starvation group), and a group provided with feed covering all its nutritional needs (control group). After 10 days, all rabbits were weighed, anesthetized, and euthanized, and liver tissue samples were collected. Histopathologic examination was performed by a surgical pathologist blinded to the experimental groups. Portal inflammation, ballooning degeneration, apoptosis and fibrosis were evaluated and statistically analyzed.
RESULTS: Severe portal inflammation, moderate portal fibrosis, slight ballooning degeneration, and moderate apoptosis were found in the full-dose PN group. Mild portal inflammation, fibrosis and mild apoptosis were found in the half-dose PN + oral nutrition group. The results of the other two groups were found normal.
CONCLUSIONS: Liver damage caused by PN combined with starvation can be devastating. The damage can be minimized by combining PN with enteral nutrition.
Copyright © 2021 Clinical and Experimental Hepatology.

Entities:  

Keywords:  histopathology; liver damage; parenteral nutrition

Year:  2021        PMID: 34295990      PMCID: PMC8284165          DOI: 10.5114/ceh.2021.106227

Source DB:  PubMed          Journal:  Clin Exp Hepatol        ISSN: 2392-1099


Introduction

Parenteral nutrition (PN) is the intravenous administration of nutrition when the use of the digestive system is not appropriate [1]. Due to advances in gastrointestinal surgery since the early 19th century, the importance of nutritional support has increased [2]. Nutritional support is one of the factors affecting the success of surgical treatments [2]. In cases in which oral nutrition is not possible, PN has increased the success of surgical treatments and has been lifesaving [3]. Parenteral nutrition is not an innocuous practice [4-7], and several studies have shown that it can have damaging effects on liver tissue [8-14]. However, none of these studies examined the effects of PN when combined with starvation. Therefore, this study aimed to conduct a histopathologic examination of the damaging effects of the combination of PN with starvation on liver tissue using transmission electron and light microscopy.

Material and methods

This study was conducted at the Experimental Animal Production and Research Center of Inonu University. Ethical approval was obtained from the Ethics Committee for Animal Experimentation of Inonu University (No. 2020/11-1).

Study groups and experimental procedures

Four groups (n = 14 each) consisting of equal numbers of female and male New Zealand rabbits were formed: a group left completely unfed and given full-dose PN (the full-dose PN group), a group provided with feed covering half its nutritional needs and given half-dose PN (the half-dose PN + oral nutrition group), a group provided with feed covering half its nutritional needs (the semi-starvation group), and a group provided with feed covering all its nutritional needs (the control group). All the animals were weighed at the start of the experiment. The differences in weight between the groups were not significant at the start of the experiment. During the experiment, the rabbits were kept under a 12-hour light and dark cycle with sufficient humidity (40-50%) at 18-21°C. All the rabbits were provided with water ad libitum. In the rabbits receiving intravenous PN, central catheters were inserted via the internal jugular vein under sterile conditions. During the procedure, 30 mg/kg ketamine (Alfamine; Ata Fen Veterinary Supplies Inc., İzmir, Turkey) and 5 mg/kg xylazine (Alfazyne 2%; Alfasan International, Woerden, Netherlands) were administered intramuscularly. A 2 cm long polyethylene catheter (20 G cutdown catheter; UPS Medical Instruments Co. Ltd., Balgat, Ankara, Turkey) was inserted into the internal jugular vein, with the animal placed in the supine position. The proximal end of the catheter was removed from the back of the vein and fixed through the subcutaneous tunnel. The parenteral and oral nutrition protocols used in this study were adopted from the work of Gürünlüoğlu et al., with slight modifications [6] (Table 1). The rabbits in the full-dose PN group received a full dose of PN (230 ml/kg),covering all their daily calorie needs (204 kcal/kg) every 24 hours (Table 1). The rabbits in the half-dose PN + oral nutrition group were provided with feed pellets covering half of their daily calorie needs (102 kcal/kg) and a half dose of PN (115 ml/kg) every 24 hours. The rabbits in the semi-starvation group were fed pellets providing 102 kcal/kg per day. The rabbits in the control group were provided with pellets covering all their daily calorie needs (204 kcal/kg).
Table 1

Parenteral nutrition (PN) solution formula (total liquid volume 230 ml/kg/d and total calories 204 kcal/kg/d)

IngredientVolume (ml)Calories (kcal)Calories percentage (%)
Full-dose PN Half dose PN + oral nutritionFull-dose PN Half dose PN + oral nutritionFull-dose PN Half dose PN + oral nutrition
20% medium long-chain fat emulsion (1)381972.236.13517.4
10% compound amino acids884434.817.4178.9
30% glucose80409748.54824
3% sodium chloride136.5
10% potassium chloride31
10% calcium glukonate31
Water-soluble vitamins (2)1/2 ampoule1/4 ampoule
Fat-soluble vitamins (3)1/2 ampoule1/4 ampoule
Trace elements (4)10.5
Total230115204102

(1) medium/long-chain fat emulsion (250 ml) composition: soybean oil 25 g, medium chain triglycerides 25 g and lecithin 3 g, linoleic acid 13 g, α-linolenic acid 1.5 g, 3 g egg phospholipids.

(2) Water-soluble vitamins composition: vitamin B1 0.5 mg, vitamin B2 0.7 mg, nicotinamide 8 mg, vitamin B6 0.2 mg, pantothenic acid 3 mg, vitamin C 20 mg, biotin 12 µg, folic acid 80 µg, vitamin B 100 µg.

(3) Fat soluble vitamins composition: vitamin A 50 µg (165 IU), vitamin D 20.25 µg (10 IU), vitamin E 0.455 µg (0.5 IU) and vitamin K 7.5 µg.

(4) Trace elements: Chromic chloride 6 H2O 5.33 µg/ml, Copper chloride 2 H2O 0.34 mg/ml, Ferric chloride 6 H2O 0.54 mg/ml, Manganese chloride 4 H2O 99.0 µg/ml, Potassium

iodide 16.6 µg/ml, Sodium fluoride 0.21 mg/ml, Sodium molybdate 2 H2O 4.85 µg/ml, Sodium selenite anhydrous 6.90 µg/ml, Zinc chloride 1.36 mg/ml.

Parenteral nutrition (PN) solution formula (total liquid volume 230 ml/kg/d and total calories 204 kcal/kg/d) (1) medium/long-chain fat emulsion (250 ml) composition: soybean oil 25 g, medium chain triglycerides 25 g and lecithin 3 g, linoleic acid 13 g, α-linolenic acid 1.5 g, 3 g egg phospholipids. (2) Water-soluble vitamins composition: vitamin B1 0.5 mg, vitamin B2 0.7 mg, nicotinamide 8 mg, vitamin B6 0.2 mg, pantothenic acid 3 mg, vitamin C 20 mg, biotin 12 µg, folic acid 80 µg, vitamin B 100 µg. (3) Fat soluble vitamins composition: vitamin A 50 µg (165 IU), vitamin D 20.25 µg (10 IU), vitamin E 0.455 µg (0.5 IU) and vitamin K 7.5 µg. (4) Trace elements: Chromic chloride 6 H2O 5.33 µg/ml, Copper chloride 2 H2O 0.34 mg/ml, Ferric chloride 6 H2O 0.54 mg/ml, Manganese chloride 4 H2O 99.0 µg/ml, Potassium iodide 16.6 µg/ml, Sodium fluoride 0.21 mg/ml, Sodium molybdate 2 H2O 4.85 µg/ml, Sodium selenite anhydrous 6.90 µg/ml, Zinc chloride 1.36 mg/ml. The PN formula contained 10% amino acids (w/v) (Primene; E. Baxter, Istanbul, Turkey), trace elements (Addamel N; Fresenius Kabi, Uppsala, Sweden), 20% (w/v) lipids (Lipofundin MCT/LCT 20%; B. Braun, Melsungen, Germany), and 30% glucose (dextrose 30%; Polyflex; Polypharma Pharmaceuticals S.A., Tekirdağ, Turkey) (Table 1). The rabbit pellets contained 18.75% protein, 6.38% cellulose, 2.28% fat, 6.2% ash, 2.45% minerals, 0.98% lysine, 0.36% methionine, and 12% starch (240 kcal/100 g; TV-01 rabbit pellet feed; DSA Agrifood Products Inc., Kırıkkale, Turkey). After 10 days, all the rabbits were weighed, anesthetized, and euthanized, and liver tissue samples were collected.

Histopathologic methods

Collection and preparation of liver tissue samples

After the rabbits were euthanized, the abdomen of each one was incised, and the liver was removed in one piece and washed with serum saline. A 2-3 cm wide and 1 cm thick tissue sample about 1 cm away from the liver capsule near the hilar area was removed and kept in 10% formalin for 24 hours. A 2 mm wide and 1 mm thick piece of tissue was removed from the same area, washed with serum saline, and kept in 2.5% glutaraldehyde for 24 hours for electron microscopic examination. After 24 hours, the samples kept in 10% formalin were sliced into pieces of 3-4 mm thickness. One piece from each sample was processed following standard procedures and buried in a paraffin block. Then sections of 3-5 µm thickness were taken from each paraffin block. The sections were stained with routine hematoxylin and eosin (H&E), routine Masson’s trichrome (MT) procedures, and anti-caspase-3 antibodies for immunohistochemical analysis.

Immunohistochemical methods

The tissue sections were deparaffinized and placed on adhesive slides. The slides were then placed in citrate buffer (pH 7.6; Thermo Scientific, Fremont, CA, USA), and antigen retrieval was performed in a pressure cooker (Retriever 2100; Aptum, Southampton, UK) at 121°C for 15 minutes. The sections were then left to cool, the citrate buffer was removed, and phosphate-buffered saline was added. The slides were washed with phosphate-buffered saline at every stage, except during protein blocking and primary antibody application. The following steps were carried out at room temperature. A horseradish peroxidase kit (Thermo Scientific) was used for immunostaining according to the manufacturer’s protocol. First, 3% hydrogen peroxide was dripped for 10 minutes. Second, a protein V-blocking solution was dripped for five minutes, followed by incubation with caspase-3 primary antibody (anti-caspase-3 antibody [ABM1C12] ab208161; Abcam, Cambridge, UK; dilution ratio 1 : 300) at room temperature for one hour. Third, the glass slides were incubated in a biotinylated goat antipolyvalent secondary antibody for 10 minutes. Streptavidin peroxidase was dripped and incubated for 10 minutes. Aminoethyl carbazole chromogen (Thermo Scientific) was dripped and incubated for 15 minutes. Finally, the slides were placed in distilled water, counterstained with Mayer’s hematoxylin, and mounted.

Scoring and histopathologic evaluation of stained liver tissue sections

Histopathologic evaluation was performed by a surgical pathologist who was blinded to the experimental groups. We evaluated portal inflammation, ballooning degeneration in the H&E-stained sections, and fibrosis in the MT-stained sections. In this study, we based the scoring system on the studies of Curran et al. [15] and Kohl et al. [16]. We adapted the scoring systems in these two studies with a few modifications. The scoring system we used is shown in Table 2.
Table 2

Histopathological scoring system

ScoreBallooning degenerationInflammationFibrosis
0NoneNoneNone
1Mild, degenerated cells covering < 25% of the porto-central distanceMild, leukocytes covering < 25% of the portal areaMild increase in connective tissue, limited to the portal area
2Moderate, degenerated cells covering 25-50% of the porto-central distanceModerate, leukocytes covering 25-50% of the portal areaModerate, fibrosis beyond the portal area
3Severe, degenerated cells covering > 50% of the porto-central distanceSevere, leukocytes beyond the portal areaSevere fibrosis with porto-portal bridging
Histopathological scoring system The presence of apoptotic cells was evaluated in the H&E-stained sections. Apoptotic cells were characterized as round to oval-shaped cells with a dark eosinophilic/dense cytoplasm and purple dense pyknotic/fragmented nuclei or fragmented apoptotic cells forming apoptotic bodies. To avoid mistaking single-cell necrosis for apoptosis, cells surrounded by inflammatory cells were not taken into consideration, even if they met the morphological criteria [17]. Eight 400× magnification areas were evaluated for each sample [17]. Apoptotic cells and the total hepatocytes (approximately 3,500 cells) in those areas were counted for each rabbit, and the ratio of apoptotic cells to total hepatocytes was calculated as an apoptosis score [14, 17]. Caspase-3-stained sections were evaluated by counting the positively stained cells in the 400× magnification areas. The ratio of stained cells to total cells was calculated for each rabbit [14, 17].

Transmission electron microscopic examination

For transmission electron microscopic examination, liver tissue samples were fixed in 2.5% glutaraldehyde buffered with 0.2 M NaH2PO4 + NaHPO4 (pH 7.4) and postfixed in 1% OsO4. After dehydration in acetone, they were embedded in epoxy resin (Araldite CY212). Thin sections (80 nm) were cut from Araldite blocks with an ultramicrotome and contrasted with uranyl acetate and lead citrate. They were then examined under a transmission electron microscope (Libra 120; Carl Zeiss NTS, Oberkochen, Germany) and photographed. Intracytoplasmic edema, organelle degeneration, and apoptotic-looking nuclei with reduced diameters in heterochromatin structures were investigated.

Statistical analysis

Values were expressed as medians and ranges. The Kruskal-Wallis test was used for comparisons between the groups. Pairwise comparisons were then performed using the Conover method. In all the tests, a two-sided value of p < 0.05 was considered statistically significant.

Results

Weight changes

Table 3 shows the results of statistical analysis of the weight changes in the four groups. The differences in weight change between the two PN groups and the control group were not statistically significant. However, the difference in weight change between the semi-starvation group and the other groups was statistically significant.
Table 3

Statistical analysis of the change in weight of rabbits in study groups during the study period

GroupsWeight before experiment (g)Weight after experiment (g)P-value
Control (n= 14)3390 ±1073392 ±1190.931
Semi-starvation (n= 14)3349 ±1553183 ±124< 0.001
Full-dose PN (n= 14)3408 ±1063392 ±850.226
Half-dose PN + oral nutrition (n= 14)3374 ±1083367 ±1370.631

PN – parenteral nutrition

Statistical analysis of the change in weight of rabbits in study groups during the study period PN – parenteral nutrition

Histopathologic results

The results of the histopathological examination are displayed in Table 4. Moderate portal fibrosis was found in the full-dose PN group, while mild fibrosis was observed in the half-dose PN + oral nutrition group. Conversely, no fibrosis was detected in the semi-starvation and control groups (Fig. 1A, B). Severe portal inflammation was found in the full-dose PN group, while mild inflammation was observed in the half-dose PN + oral nutrition group. In contrast, no inflammation was detected in the semi-starvation and control groups (Fig. 1C, D). Slight ballooning degeneration was observed in the full-dose PN group. Conversely, no ballooning degeneration was detected in the other three groups (Fig. 2A). Moderate apoptosis was found in the full-dose PN group, while mild apoptosis was detected in the half-dose PN + oral nutrition group. Minimal apoptosis was found in the semi-starvation and control groups (Figs. 2B and 3A). Moderate caspase-3 expression was detected in the full-dose PN group, while mild expression was found in the half-dose PN + oral nutrition group. Minimal expression was found in the semi-starvation and control groups (Figs. 3B and 4A-C). All differences were statistically significant (p < 0.001).
Table 4

Histopathological and immunohistochemical evaluation results

Control (n= 14)Semi-starvation (n = 14)Half-dose PN + oral nutrition (n = 14)Full-dose PN (n = 14)
Portal fibrosis0 (0-0)a0 (0-0)a1 (1-2)b2 (1-3)c
Apoptosis0.01 (0.01-0.02)a0.01 (0.01-0.02)a0.05 (0.04-0.06)b0.23 (0.11-0.43)c
Portal inflammation0 (0-1)a0 (0-1)a1 (1-2)b3 (1-3)c
Balloon degeneration0 (0-0)a0 (0-0)a0 (0-1)a1 (1-2)b
Caspase-3 expression0.01 (0.01-0.03)a0.01 (0.01-0.03)a0.04 (0.03-0.06)b0.48 (0.25-0.76)c
P-value< 0.001< 0.001< 0.001< 0.001

The difference between the groups with different superscript letters are statistically significant.

PN – parenteral nutrition

Fig. 1

Light microscope liver tissue images of the parenteral nutrition (PN) groups. A) Fibrosis beyond the portal area in the full-dose PN group (white arrows) (Masson’s trichrome, 200× magnification). B) The portal area of the half-dose PN + oral nutrition group shows a mild degree of fibrosis confined to the portal area (white arrows) (Masson’s trichrome, 200× magnification). C) Severe degree of inflammation in the portal and periportal area of a subject from the full-dose PN group (black arrows) (hematoxylin and eosin, 200× magnification). D) Mild degree of portal inflammation in a subject from the half-dose PN + oral nutrition group (black arrows) (hematoxylin and eosin, 200× magnification)

Fig. 2

A) In this picture, which belongs to the full-dose parenteral nutrition group, some hepatocytes with balloon degeneration are shown with white arrows (hematoxylin and eosin, 400× magnification). B) Some apoptotic cells are indicated with white arrows here. The picture belongs to a subject from the full-dose parenteral nutrition group (hematoxylin and eosin, 400× magnification)

Fig. 3

Liver tissue apoptosis and caspase-3 expression evaluation results of the four groups. A) Apoptosis findings evaluation results. B) Caspase-3 expression evaluation results

Light microscope liver tissue images of the parenteral nutrition (PN) groups. A) Fibrosis beyond the portal area in the full-dose PN group (white arrows) (Masson’s trichrome, 200× magnification). B) The portal area of the half-dose PN + oral nutrition group shows a mild degree of fibrosis confined to the portal area (white arrows) (Masson’s trichrome, 200× magnification). C) Severe degree of inflammation in the portal and periportal area of a subject from the full-dose PN group (black arrows) (hematoxylin and eosin, 200× magnification). D) Mild degree of portal inflammation in a subject from the half-dose PN + oral nutrition group (black arrows) (hematoxylin and eosin, 200× magnification) A) In this picture, which belongs to the full-dose parenteral nutrition group, some hepatocytes with balloon degeneration are shown with white arrows (hematoxylin and eosin, 400× magnification). B) Some apoptotic cells are indicated with white arrows here. The picture belongs to a subject from the full-dose parenteral nutrition group (hematoxylin and eosin, 400× magnification) Liver tissue apoptosis and caspase-3 expression evaluation results of the four groups. A) Apoptosis findings evaluation results. B) Caspase-3 expression evaluation results Light microscope images of liver tissue caspase-3 expression. A) This picture shows severe caspase-3 expression (black arrows) in the full-dose PN group. B) This picture shows mild caspase-3 expression (black arrows) in the half-dose PN + oral nutrition group. C) Control group image Histopathological and immunohistochemical evaluation results The difference between the groups with different superscript letters are statistically significant. PN – parenteral nutrition

Transmission electron microscopic findings

The ultrastructural appearance of liver sections of the half-dose PN + oral nutrition, semi-starvation, and control groups was normal (Fig. 5A). In contrast, the liver sections of the full-dose PN group exhibited profound ultrastructural changes in hepatocytes. Many lipid vacuoles of different diameters and variably sized membrane-bound vacuoles containing electron-dense material, intracytoplasmic edema, and accumulated electron-dense glycogen granules were observed in the hepatocyte cytoplasm (Fig. 5B, C).
Fig. 5

A) Half-dose parenteral nutrition (PN) + oral nutrition group: normal ultrastructural appearance of hepatocyte, hepatocyte nuclei (n). Uranyl acetate-lead citrate, transmission electron microscope (TEM), scale bar = 2 μm, original 6300× magnification. B) Full-dose PN group: hepatocyte nuclei (n) intracytoplasmic lipid vacuole (v), intracytoplasmic edema (e), glycogen granules (arrow) in hepatocytes. Uranyl acetate-lead citrate, TEM, scale bar = 5 μm, original 4000× magnification. C) Full-dose PN group: hepatocyte nuclei (n), intracytoplasmic lipid vacuole (v), intracytoplasmic edema (e), glycogen granules (white arrow), membrane-bound vacuole containing electron-dense material in hepatocytes (black arrow). Uranyl acetate-lead citrate, TEM, scale bar = 5 μm, original 6000× magnification

A) Half-dose parenteral nutrition (PN) + oral nutrition group: normal ultrastructural appearance of hepatocyte, hepatocyte nuclei (n). Uranyl acetate-lead citrate, transmission electron microscope (TEM), scale bar = 2 μm, original 6300× magnification. B) Full-dose PN group: hepatocyte nuclei (n) intracytoplasmic lipid vacuole (v), intracytoplasmic edema (e), glycogen granules (arrow) in hepatocytes. Uranyl acetate-lead citrate, TEM, scale bar = 5 μm, original 4000× magnification. C) Full-dose PN group: hepatocyte nuclei (n), intracytoplasmic lipid vacuole (v), intracytoplasmic edema (e), glycogen granules (white arrow), membrane-bound vacuole containing electron-dense material in hepatocytes (black arrow). Uranyl acetate-lead citrate, TEM, scale bar = 5 μm, original 6000× magnification

Evaluation of results

The histopathologic results suggest that PN combined with starvation could cause moderate portal fibrosis and apoptosis, severe portal inflammation, and mild ballooning degeneration. When PN was combined with oral nutrition, portal inflammation, portal fibrosis, apoptosis, and caspase-3 expression were milder. Although liver damage still occurred, a devastating effect was avoided. Our findings also showed that hunger itself, which resulted in slight weight loss, does not cause damage to the liver.

Discussion

Many studies have investigated the negative effects of PN on the liver [8-15]. These studies have mainly focused on the components of PN formulas [8-15]. Our study is the first to investigate how the damaging effect of PN on the liver can be minimized by combining it with oral feeding. The development of steatosis in liver tissue is one of the important negative effects of PN [1]. A study on newborn piglets reported that PN caused steatosis in liver tissue [8]. The authors found that the molecular and morphological pathogenesis of PN-related liver damage is associated with apoptosis mediated by the mitochondrial and Fas pathways [8]. In our study, we found that PN caused moderate apoptosis in liver tissue in the case of total starvation, but the effect was quite mild when PN was combined with enteral nutrition. An experimental study investigating the relationship between liver damage and oxidative stress caused by PN found portal inflammation, proliferation of bile ducts, increased bile pigments in hepatocytes, and diffuse steatosis in the entire liver [14]. The authors suggested that the severity of the damage depends on the duration of PN administration [14]. Some studies have reported that the liver damage caused by PN is associated with the lipids in its formula [18-20]. For example, Tazuke et al. [18] found that the damage to the liver caused by PN is due to the lipids in its composition, which causes apoptosis. Similarly, La Scala et al. [19] found that cholestasis developing during PN is associated with the lipids contained in the formula. Conversely, the authors suggested that hepatocellular damage was not associated with lipids [19]. Nakagawa et al. found that medium-chain triglycerides (MCT) in PN formulas caused steatosis in the liver due to their disruptive effect on nitrogen balance and albumin levels, whereas PN formulas containing long-chain triglycerides caused milder fatty changes in the liver [20]. Various lipid emulsions are used in PN compositions [21]. Intralipid, made from soybean oil, contains α-tocopherol, oleic acid, linoleic acid, palmitic acid, α-linolenic acid, stearic acid, and the highest phytosterol concentration of all lipid emulsions [21, 22]. SMOFlipid 20% is a mixture of soybean oil, MCT, fish oil, and olive oil and contains α-tocopherol. It consists of eicosapentaenoic acid, α-linolenic acid, linoleic acid, palmitic acid, oleic acid, docosahexaenoic acid, arachidonic acid, and stearic acid and contains less phytosterol than other lipid emulsions [21, 22]. Lipofundin 20% is produced from soybean oil and contains MCT and moderate amounts of phytosterol. It consists of palmitic acid, arachidonic acid, oleic acid, α-linolenic acid, stearic acid, and linoleic acid. Omegaven is produced from fish oil. It consists of egg phospholipids, eicosapentaenoic acid, linoleic acid, docosahexaenoic acid, α-linolenic acid, and glycerol and contains no phytosterol [23]. Cholestasis during PN has been associated with the phytosterol content of the lipid emulsions [21]. Phytosterol omega-6 contains polyunsaturated fatty acids, which can cause cholestasis [21]. Omega-3 fatty acids, on the other hand, have been found to exert a hepatoprotective effect [21]. Lipofundin has been associated with cholestasis due to its omega-6 content [21], whereas SMOFlipid and Omegaven have been suggested to exert a hepatoprotective effect [21, 23]. However, because SMOFlipid is poor in lipids and Omegaven does not contain phytosterol, which is vital for the development of the central nervous system and retina, their long-term use is not recommended in preterm infants [24]. In this study, we used Lipofundin 20%. However, although the combination of PN and starvation caused moderate liver disease, the combination of PN with enteral nutrition caused only mild damage. We believe that when enteral nutrition is possible, it can reduce the damaging effects of PN on the liver to some extent. Amino acid solutions contained in PN formulas can significantly contribute to the damage caused to the liver. Bellini et al. reported that the composition of amino acid solutions contained in PN formulas plays an important role and that the presence of methyl donor amino acids could mitigate the cholestatic effect of PN on the liver [25]. Hat et al. suggested that amino acid solutions in appropriate concentrations could be effective in preventing liver damage [26]. The PN formula used in our study contained 10% amino acid solution. PN is a nutritional technique in which fluids and nutrients needed by the body are given intravenously. We speculate that in the event of a complete disabling of the gastrointestinal tract, hormonal regulatory mechanisms are completely disabled, thus not ensuring proper distribution and proper use of all components of PN at the cellular level in the body. This may have set the stage for some negative conditions in the body, such as hyperglycemia and oxidative stress. Under normal circumstances, we believe that these hormones are released from the digestive tract in the case of nutrients entering [6]. We think that the severity of the liver damage, which is related to PN combined with hunger, may be associated with a lack of nutrient inflow into the digestive tract. We speculate that these negative effects of PN combined with hunger on the liver can be minimized by adding oral nutrition to PN.

Conclusions

Parenteral nutrition may cause damage to the liver, which can be devastating when combined with starvation. However, the damage can be minimized by combining PN with enteral nutrition.
  24 in total

1.  Influence of different intravenous lipid emulsions on hepatobiliary dysfunction in a rabbit model.

Authors:  Martina Kohl; Thilo Wedel; Andreas Entenmann; Julia Stuttmann; Meike Bendiks; Steffan Loff; Stefan Köster; Stefan Ortfeld; Inge Bos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-02       Impact factor: 2.839

Review 2.  Various methods available for detection of apoptotic cells--a review.

Authors:  M Archana; T L Yogesh; K L Kumaraswamy
Journal:  Indian J Cancer       Date:  2013 Jul-Sep       Impact factor: 1.224

3.  Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction.

Authors:  Wei Cai; Jiang Wu; Li Hong; Yuanfei Xu; Qingya Tang; Chengren Shi
Journal:  J Pediatr Surg       Date:  2006-10       Impact factor: 2.545

Review 4.  Parenteral Nutrition in Very Low Birth Weight Preterm Infants.

Authors:  Arieh Riskin; Corina Hartman; Raanan Shamir
Journal:  Isr Med Assoc J       Date:  2015-05       Impact factor: 0.892

5.  The addition of lipids increases the total parenteral nutrition-associated cholestasis in the rat.

Authors:  G C La Scala; C Le Coultre; B G Roche; P Bugmann; D C Belli
Journal:  Eur J Pediatr Surg       Date:  1993-08       Impact factor: 2.191

6.  The effect of cholecystokinin-octapeptide on the hepatobiliary dysfunction caused by total parenteral nutrition.

Authors:  T J Curran; I Uzoaru; J B Das; G Ansari; J G Raffensperger
Journal:  J Pediatr Surg       Date:  1995-02       Impact factor: 2.545

7.  Effects of lipid administration on liver apoptotic signals in a mouse model of total parenteral nutrition (TPN).

Authors:  Yuko Tazuke; Robert A Drongowski; Imad Btaiche; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2004-03-18       Impact factor: 1.827

8.  Early developments and clinical applications of total parenteral nutrition.

Authors:  Stanley J Dudrick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2003 Jul-Aug       Impact factor: 4.016

9.  Nutrition support to patients undergoing gastrointestinal surgery.

Authors:  Nicola Ward
Journal:  Nutr J       Date:  2003-12-01       Impact factor: 3.271

10.  Hepatic Overexpression of GRP94 in a Rabbit Model of Parenteral Nutrition-Associated Liver Disease.

Authors:  Xueping Zhu; Xiaomin Zhang; Lingling Yu; Yumin Xu; Xing Feng; Jian Wang
Journal:  Gastroenterol Res Pract       Date:  2015-03-30       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.